These results confirm the importance of investigating the CD34+ fraction and indicate that TIMD4, VCAM1, CYBB, DNTT, AREG, and S100A12 may play a central role in MPN pathophysiology. This evidence concerns the gene VCAM1 and myeloproliferative disorder.